Search All News
A drug given to nearly 10 percent of all pregnant women to prevent severe respiratory ailments in preterm babies also reduces health care costs, according to a new study by Columbia researchers.
New research in mice suggests omega-3s may help prevent miscarriage, preterm delivery, and stillbirth caused by uterine infections with bacteria commonly found in the mouth.
A study from Columbia University researchers suggests that DNA sequencing can help diagnose the underlying genetic causes of fetal anomalies found during prenatal ultrasounds.
A new study by Columbia researchers suggests aspirin may lower stroke risk among middle-aged women with a history of preeclampsia.
- May 25, 2017
Certain women with preeclampsia are more likely to have a pregnancy-related stroke, finds a new study led by Columbia neurologists.
- May 5, 2017
Created by CUMC researchers, the Phendo app allows women to track their endometriosis symptoms, adding to our understanding of the disease.
- April 18, 2017
Sexual reproduction may have never evolved if organisms hadn’t developed a way to restrain the immune system during fertilization, according to a new CUMC study.
- September 7, 2016
The antidepressant fluoxetine decreases bone density, but a new CUMC study suggests adding a beta-blocker to treatment can prevent the loss of bone.
- August 16, 2016
Expanded prenatal genetic testing may increase the detection of carriers for a variety of potentially serious conditions.
- May 18, 2016
After rotating through the ob/gyn clerkship, Emily Woodbury, MD’16, helped to improve it for future students.
- March 23, 2016
Dr. Cynthia Gyamfi-Bannerman describes new practice guidelines for the use of antenatal corticosteroids in mothers at risk of late preterm delivery.
- February 4, 2016
Researchers from Columbia University Medical Center and NewYork-Presbyterian have found that using corticosteroids in mothers at risk for late preterm delivery reduced the incidence of severe respiratory complications in their babies.
- November 12, 2015
While stigma delays progress against HIV for many vulnerable groups, few groups have been less visible than female drug users.